Characterization of growth hormone secretagogue small molecule ibutamoren (MK-0677) and its possible metabolites in thoroughbred horses for doping control.
Quick Facts
What This Study Found
22 metabolites of ibutamoren were identified, detectable for up to 96 hours.
Key Numbers
How They Did This
The study used liquid chromatography and high-resolution mass spectrometry to analyze ibutamoren and its metabolites in thoroughbred horses after oral administration.
Why This Research Matters
Understanding how ibutamoren metabolizes helps improve doping control in competitive sports. This knowledge can help ensure fair competition by identifying illegal substance use.
What This Study Doesn't Tell Us
The study is limited to thoroughbred horses, and results may not directly apply to other species or humans.
Trust & Context
- Original Title:
- Characterization of growth hormone secretagogue small molecule ibutamoren (MK-0677) and its possible metabolites in thoroughbred horses for doping control.
- Published In:
- Rapid communications in mass spectrometry : RCM, 36(18), e9337 (2022)
- Authors:
- Philip, Moses, Karakka Kal, Abdul Khader, Subhahar, Michael Benedict, Karatt, Tajudheen K, Mathew, Binoy, Koshy, Shino Ann
- Database ID:
- RPEP-06432
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06432APA
Philip, Moses; Karakka Kal, Abdul Khader; Subhahar, Michael Benedict; Karatt, Tajudheen K; Mathew, Binoy; Koshy, Shino Ann. (2022). Characterization of growth hormone secretagogue small molecule ibutamoren (MK-0677) and its possible metabolites in thoroughbred horses for doping control.. Rapid communications in mass spectrometry : RCM, 36(18), e9337. https://doi.org/10.1002/rcm.9337
MLA
Philip, Moses, et al. "Characterization of growth hormone secretagogue small molecule ibutamoren (MK-0677) and its possible metabolites in thoroughbred horses for doping control.." Rapid communications in mass spectrometry : RCM, 2022. https://doi.org/10.1002/rcm.9337
RethinkPeptides
RethinkPeptides Research Database. "Characterization of growth hormone secretagogue small molecu..." RPEP-06432. Retrieved from https://rethinkpeptides.com/research/philip-2022-characterization-of-growth-hormone
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.